Dr. Fayad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Unit 429
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1994 - 1997- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1993 - 1994
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1990 - 1993
Universidad Catolica de Santiago de GuayaquilClass of 1985
Certifications & Licensure
FL State Medical License 1991 - Present
TX State Medical License 1995 - 2024
OK State Medical License 2020 - 2021
AZ State Medical License 1999 - 2014
NV State Medical License 1997 - 2011
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy Start of enrollment: 2002 May 01
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Start of enrollment: 2002 Feb 01
- Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger Start of enrollment: 2005 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system i...Anath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, Rami Eldaya, Sairah Ahmed, Swaminathan P Iyer, Loretta J Nastoupil, Jason Westin, Ranjit Nair, Luis Fayad, Luis Malpi...> ;Leukemia & Lymphoma. 2024 May 1
- Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.Andrew P Jallouk, Naishu Kui, Ryan Sun, Jason R Westin, Raphael E Steiner, Ranjit Nair, Loretta J Nastoupil, Luis E Fayad, Ajlan Al Zaki, Misha Hawkins, Sherry Adkins,...> ;Haematologica. 2024 May 1
- Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 s...Max J Gordon, Lei Feng, Paolo Strati, Hun Ju Lee, Fredrick B Hagemeister, Jason R Westin, Felipe Samaniego, Mario L Marques-Piubelli, Francisco Vega Vazquez, Edwin R P...> ;Cancer. 2024 Mar 15
- Join now to see all
Journal Articles
- Long‐Term Overall‐ and Progression‐Free Survival After Pentostatin, Cyclophosphamide and Rituximab Therapy for Indolent Non‐Hodgkin LymphomaPeter McLaughlin, M Alma Rodriguez, Sattva S Neelapu, Anas Younes, Lei Feng, Michelle A Fanale, Felipe Samaniego, Barbara Pro, Luis Fayad, Fredrick Hagemeister, Jorge ..., British Journal of Haematology
- Rituximab with ABVD vs ABVD for Advanced Stage High-Risk Classical Hodgkin Lymphoma: A Randomized Phase II StudyFrancesco Turturro, Luis E Fayad, Anas Younes, Michelle Fanale, Yasuhiro Oki, Hun Ju Lee, Nancy L Bartlett, Haematologica
Abstracts/Posters
- Predictive Factors of Response and Survival of Lenalidomide and Rituximab As Initial Treatment of Follicular LymphomaLuis Fayad, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase I/II Study of Lenalidomide Plus Obinutuzumab in Relapsed Indolent LymphomaLuis E. Fayad, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell LymphomaLuis Fayad, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Seven Year Follow up and Comparison of Dosing Strategies from the Pivotal Phase II Clinical Trial of Lenalidomide Plus Rituximab (R) in Previously Untreated Follicular...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clinical and Genomic Characteristics in De Novo Blastoid/Pleomorphic (dnMCL) and Transformed Blastoid/Pleomorphic (t-MCL) Mantle Cell Lymphoma (MCL) in the Ibrutinib E...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Hodgkin’s Lymphoma Survivor: How My Cancer Journey Led to a Career in Reproductive LawNovember 7th, 2017
Hodgkin’s Lymphoma Survivor: Why I Froze My Eggs Before Cancer TreatmentOctober 17th, 2017
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
